Dr. Mohamad Khaled, a Neurosurgeon, Joins Ayer Institute

Ayer Institute Adds Neurosurgeon
Print icon

Hartford HealthCare’s Ayer Neuroscience Institute announced the appointment of Dr. Mohamad Khaled as a neurosurgeon seeing patients both at Hartford Hospital and in offices in Enfield.

“Dr. Khaled’s broad base of expertise enhances the services we already provide to patients suffering from various diseases and tumors of the brain and spine,” said Dr. Mark Alberts, physician-in-chief of Ayer Neuroscience Institute, “His highly specialized surgical skills help us offer people world-class options for brain and spine conditions without having to travel far.”

Dr. Khaled comes to Hartford HealthCare from Baystate Health, where he was director of functional neurosurgery and launched the Deep Brain Stimulation Program, the first of its kind in western Massachusetts. He was also an assistant professor of surgery at the University of Massachusetts Medical Center-Baystate.

His areas of clinical interest include deep brain stimulation; epilepsy surgery; cervical, thoracic and lumbar spine surgery, including minimally-invasive spine surgery, cervical spine deformity correction surgery and spine tumors; surgery for pain; and brain tumors. His research has included work on MR-guided ultrasound lesioning in deep brain stimulation and comparing radiofrequency, GammaKnife radiosurgery and focused ultrasound lesions in the brain.

Dr. Khaled, who is fluent in English and Arabic, earned his medical degree from Ain Shams University in Cairo, Egypt, and completed a residency at Wayne State University/Detroit Medical Center. He also completed fellowships in epilepsy surgery and pediatric neurosurgery at Cleveland Clinic. He is a member of the American Association of Neurological Surgeons and the Congress of Neurological Surgeons.

Dr. Mohamad Khaled, a member of the Hartford HealthCare Medical Group, is accepting patients by referral in office at 85 Seymour St., Suite 1003, Hartford, or 100 Hazard Ave., first floor, Enfield. For an appointment, call 860.696.2290.


What's New

Dr. Khalid M. Abbed

Renowned Spine Care Neurosurgeon joins Hartford HealthCare in Southwestern Connecticut

BRIDGEPORT —Hartford HealthCare announces the appointment of Dr. Khalid M. Abbed, one of New England’s leading neurosurgeons, as Co-Physician-in-Chief of its Ayer Neuroscience Institute. An experienced neurosurgeon and hospital director with a demonstrated history of leadership in the healthcare industry, he will oversee neurosurgical services and lead the Ayer Neuroscience...


HHC Neurology Services expand to Thomaston

The Hartford HealthCare Ayer Neuroscience Institute at Charlotte Hungerford Hospital has recently welcomed Nabi Chowdhury, MD, who is now accepting patients one day a week at the new CHH Specialty Care office located at 76 Watertown Road, Thomaston. The practice offers neurological evaluations, diagnosis and treatment of diseases and disorders...

Epilepsy

How Specialty Care Can Lower Risk of Death From Epilepsy

Patients getting epilepsy care in a specialty center had a lower chance of death, according to a Canadian study released in the Journal of the American Medical Society Neurology. Dr. Gabriel Martz, director of The Epilepsy Center at Hartford HealthCare’s Ayer Neuroscience Institute, said in some cases the challenges of...

Dr. Elena Bortan

Movement Disorders Care Comes to Mystic

Much as the design of the new Hartford HealthCare facility at 100 Perkins Farms Drive in Mystic reflects the vibe of coastal community, the location of specialists from the HHC Ayer Neuroscience Institute’s Chase Family Movement Disorders Center to the facility answers a demand for high-quality care and support in...

Ozzy Osbourne

How Physical Therapy Might Help Ozzy Osbourne, Other Parkinson’s Patients

For years, substance abuse might have been the presumed root of shaking and stumbling by rock star Ozzy Osbourne, but the 71-year-old rocker recently revealed that Parkinson’s disease is to blame. Parkinson’s, a chronic and progressive movement disorder for which there is treatment but no cure, affects more than 200,000...